These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 21518001

  • 21. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
    Schubert S, Abdul-Khaliq H, Lehmkuhl HB, Yegitbasi M, Reinke P, Kebelmann-Betzig C, Hauptmann K, Gross-Wieltsch U, Hetzer R, Berger F.
    Pediatr Transplant; 2009 Feb; 13(1):54-62. PubMed ID: 18518912
    [Abstract] [Full Text] [Related]

  • 22. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].
    Merlino C, Giacchino F, Bergallo M, Bonello F, Bollero C, Segoloni GP, Cavallo R.
    G Ital Nefrol; 2003 Feb; 20(2):170-5. PubMed ID: 12746803
    [Abstract] [Full Text] [Related]

  • 23. Association between Epstein-Barr virus seroconversion and immunohistochemical changes in tonsils of pediatric solid organ transplant recipients.
    Shapiro NL, Tang CG, Bhattacharyya N.
    Laryngoscope; 2011 Aug; 121(8):1718-25. PubMed ID: 21792960
    [Abstract] [Full Text] [Related]

  • 24. Induction of pre-transplant Epstein-Barr virus (EBV) infection by donor blood transfusion in EBV-seronegative recipients may reduce risk of post-transplant lymphoproliferative disease in adolescent renal transplant patients: report of two cases.
    Babel N, Gabdrakhmanova L, Hammer M, Rosenberger C, Oppert M, Volk HD, Reinke P.
    Transpl Infect Dis; 2005 Aug; 7(3-4):133-6. PubMed ID: 16390402
    [Abstract] [Full Text] [Related]

  • 25. Monitoring of Epstein-Barr viral load in pediatric heart and lung transplant recipients by real-time polymerase chain reaction.
    Benden C, Aurora P, Burch M, Cubitt D, Lloyd C, Whitmore P, Neligan SL, Elliott MJ.
    J Heart Lung Transplant; 2005 Dec; 24(12):2103-8. PubMed ID: 16364857
    [Abstract] [Full Text] [Related]

  • 26. Posttransplantation lymphoproliferative disorder--the great mimic in liver transplantation: appraisal of the clinicopathologic spectrum and the role of Epstein-Barr virus.
    Koch DG, Christiansen L, Lazarchick J, Stuart R, Willner IR, Reuben A.
    Liver Transpl; 2007 Jun; 13(6):904-12. PubMed ID: 17539010
    [Abstract] [Full Text] [Related]

  • 27. Clinical significance of peripheral blood Epstein-Barr viral load monitoring using polymerase chain reaction in renal transplant recipients.
    Toyoda M, Moudgil A, Warady BA, Puliyanda DP, Jordan SC.
    Pediatr Transplant; 2008 Nov; 12(7):778-84. PubMed ID: 18331541
    [Abstract] [Full Text] [Related]

  • 28. Epstein-Barr virus-associated pneumonia in patients with post-transplant lymphoproliferative disease after hematopoietic stem cell transplantation.
    Liu QF, Fan ZP, Luo XD, Sun J, Zhang Y, Ding YQ.
    Transpl Infect Dis; 2010 Aug 01; 12(4):284-91. PubMed ID: 20345506
    [Abstract] [Full Text] [Related]

  • 29. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
    Knight JS, Tsodikov A, Cibrik DM, Ross CW, Kaminski MS, Blayney DW.
    J Clin Oncol; 2009 Jul 10; 27(20):3354-62. PubMed ID: 19451438
    [Abstract] [Full Text] [Related]

  • 30. Early evidence of lymphoproliferative disorder: post-transplant monitoring of Epstein-Barr infection in adult and pediatric patients.
    Gaeta A, Nazzari C, Verzaro S, Latte MC, Fabri G, Scateni S, Raggi C, Lubrano R, Mancini C.
    New Microbiol; 2006 Oct 10; 29(4):231-41. PubMed ID: 17201089
    [Abstract] [Full Text] [Related]

  • 31. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
    Hurwitz M, Desai DM, Cox KL, Berquist WE, Esquivel CO, Millan MT.
    Pediatr Transplant; 2004 Jun 10; 8(3):267-72. PubMed ID: 15176965
    [Abstract] [Full Text] [Related]

  • 32. Post-transplant lymphoproliferative disease in pediatric lung transplant recipients: recent advances in monitoring.
    Elidemir O, Kancherla BS, Schecter MG, McKenzie ED, Morales DL, Heinle JS, Mallory GB.
    Pediatr Transplant; 2009 Aug 10; 13(5):606-10. PubMed ID: 19017289
    [Abstract] [Full Text] [Related]

  • 33. Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction.
    Kinch A, Oberg G, Arvidson J, Falk KI, Linde A, Pauksens K.
    Scand J Infect Dis; 2007 Aug 10; 39(3):235-44. PubMed ID: 17366054
    [Abstract] [Full Text] [Related]

  • 34. In situ hybridization for Epstein-Barr virus NotI repeats in posttransplant lymphoproliferative disorder.
    Montone KT, Friedman H, Hodinka RL, Hicks DG, Kant JA, Tomaszewski JE.
    Mod Pathol; 1992 May 10; 5(3):292-302. PubMed ID: 1323104
    [Abstract] [Full Text] [Related]

  • 35. Comparison of serum and whole blood levels of cytomegalovirus and Epstein-Barr virus DNA.
    Kullberg-Lindh C, Olofsson S, Brune M, Lindh M.
    Transpl Infect Dis; 2008 Oct 10; 10(5):308-15. PubMed ID: 18466193
    [Abstract] [Full Text] [Related]

  • 36. Soluble CD30: a serum marker for Epstein-Barr virus-associated lymphoproliferative diseases.
    Haque T, Chaggar T, Schafers J, Atkinson C, McAulay KA, Crawford DH.
    J Med Virol; 2011 Feb 10; 83(2):311-6. PubMed ID: 21181928
    [Abstract] [Full Text] [Related]

  • 37. Timing of Epstein-Barr virus acquisition and the course of posttransplantation lymphoproliferative disorder in children.
    Wu JF, Ho MC, Ni YH, Chen HL, Lu CY, Hsu HY, Lee PH, Chang MH.
    Transplantation; 2009 Mar 15; 87(5):758-62. PubMed ID: 19295323
    [Abstract] [Full Text] [Related]

  • 38. Post-transplant lymphoproliferative disorders and Epstein-Barr virus DNAemia in a cohort of lung transplant recipients.
    Baldanti F, Rognoni V, Cascina A, Oggionni T, Tinelli C, Meloni F.
    Virol J; 2011 Sep 05; 8():421. PubMed ID: 21892950
    [Abstract] [Full Text] [Related]

  • 39. Risk factors for posttransplant lymphoproliferative disorder in pediatric liver transplant recipients with cytomegalovirus antigenemia.
    Kim JM, Lee SK, Kim SJ, Joh JW, Kwon CH, Choe YH, Shin M, Kim EY, Moon JI, Jung GO, Choi GS.
    Transplant Proc; 2010 Apr 05; 42(3):895-9. PubMed ID: 20430199
    [Abstract] [Full Text] [Related]

  • 40. High incidence of posttransplant lymphoproliferative disease in pediatric patients with cystic fibrosis.
    Cohen AH, Sweet SC, Mendeloff E, Mallory GB, Huddleston CB, Kraus M, Kelly M, Hayashi R, DeBaun MR.
    Am J Respir Crit Care Med; 2000 Apr 05; 161(4 Pt 1):1252-5. PubMed ID: 10764320
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.